Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

WHO vows nothing 'ridiculous' as public submits ideas to rename monkeypox

Published 16/08/2022, 17:16
Updated 16/08/2022, 17:21
© Reuters. FILE PHOTO: Test tubes labelled "Monkeypox virus positive" are seen in this illustration taken May 22, 2022. REUTERS/Dado Ruvic/Illustration

By Emma Farge and Jennifer Rigby

GENEVA/LONDON (Reuters) - Poxy McPoxface, TRUMP-22 or Mpox: these some of the ideas sent in by the public to the World Health Organization as it seeks a new name for monkeypox.

Often disease names are chosen behind closed doors by a technical committee, but the WHO has this time decided to open up the process to the public. After a slow start, dozens of submissions have now been made from a range of contributors including academics, doctors, and a gay community activist.

They range from the technical (OPOXID-22, submitted by Harvard Medical School emergency physician Jeremy Faust) to the farcical (Poxy McPoxface, submitted by Andrew Yi in an allusion to Boaty McBoatface - almost the name of a British polar research vessel after a public vote on the choice).

Pressure is growing for a new name for the disease, in part because critics say it is misleading, since monkeys are not the original animal host. A group of leading scientists wrote a position paper in June calling for a name that was "neutral, non-discriminatory and non-stigmatizing" amid fears the name can be used in a racist way.

Until this year, monkeypox has mainly spread only in a group of countries in west and central Africa.

"It's very important we find a new name for monkeypox because this is best practice not to create any offence to an ethical group, a region, a country, an animal etc," WHO spokesperson Fadela Chaib said on Tuesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The WHO is very concerned by this issue and we want to find a name that is not stigmatising," she added without giving a timeline.

One of the more popular submissions so far is Mpox, submitted by Samuel Miriello, director of a men's health organization RÉZO which is already using the name in its outreach campaigns in Montreal, Canada.

"When you remove the monkey imagery, people seem to understand more quickly that there's an emergency that needs to be taken seriously," he told Reuters.

Another proposal, TRUMP-22, appeared to be refer to former U.S. President Donald Trump who used the controversial term "Chinese virus" for the new coronavirus, although its author said it stood for "Toxic Rash of Unrecognized Mysterious Provenance of 2022".

Submissions mocking the gay community had earlier been posted but were later removed from the WHO site.

The WHO has a mandate to assign new names to existing diseases under the International Classification of Diseases. It has already renamed monkeypox virus variants, or clades, changing them from African regions to Roman numerals.

The WHO said it would decide among the proposals "according to their scientific validity, their acceptability, their pronounceability (and) whether they can be used in different languages".

"I am sure we will not come up with a ridiculous name," said Chaib.

Monkeypox was first discovered in 1958 and named after the first animal to show symptoms. The WHO declared the current outbreak a public health emergency last month having reported more than 32,000 cases from over 80 countries.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.